Emergency Trauma

  • Gradual increase of nonoperative management of selected abdominal gunshot wounds

    on March 24th, 2017
    FROM THE JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS Selective nonoperative management of abdominal gunshot wounds has progressed from heresy a few years ago to established practice now, at least at Level I and Level II trauma centers across New England, according to a report published online in the[...]
  • Norepinephrine shortage linked to mortality in patients with septic shock

    on March 21st, 2017
    FROM ISICEM A national shortage of norepinephrine in the United States was associated with higher rates of mortality among patients hospitalized with septic shock, investigators reported. Rates of in-hospital mortality in 2011 were 40% during quarters when hospitals were facing shortages and 36% whe[...]
  • Protocol speeds thrombectomy stroke patients from primary centers

    on March 6th, 2017
    AT THE INTERNATIONAL STROKE CONFERENCE HOUSTON (FRONTLINE MEDICAL NEWS) – A novel protocol designed to speed patients with large-vessel occlusion strokes in and out of primary stroke centers and on to centers where they can undergo definitive thrombectomy treatment produced significant improvement[...]
  • Patient transfer before thrombectomy worsens stroke outcomes

    on March 6th, 2017
    AT THE INTERNATIONAL STROKE CONFERENCE HOUSTON (FRONTLINE MEDICAL NEWS) – Drip and ship many not be the most time-effective way to treat acute ischemic stroke patients who are candidates for endovascular thrombectomy. Results from two separate real-world, observational studies showed that acute is[...]
  • Ebola research update: January-February 2017

    on March 2nd, 2017
    The struggle to defeat Ebola virus disease continues globally, although it may not always make the headlines. To catch up on what you may have missed, here are some notable news items and journal articles published over the past few weeks that are worth a second look. Italian researchers observed th[...]
  • Antihypertensive protocol cuts eclampsia rates

    on February 27th, 2017
    AT THE PREGNANCY MEETING LAS VEGAS (FRONTLINE MEDICAL NEWS) – A multisite trial that implemented a protocol for use of intravenous hydralazine or labetalol together with magnesium sulfate for critically high blood pressures in pregnancy saw maternal eclampsia rates fall by 46% and severe maternal [...]
  • Tap patients with suspected HIV neurosyphilis regardless of symptoms

    on February 27th, 2017
    AT CROI SEATTLE (FRONTLINE MEDICAL NEWS) – Neurologic symptoms are an unreliable indicator of neurosyphilis in patients with HIV, according to University of Washington, Seattle, investigators. After tapping 385 HIV patients with untreated syphilis and possible central nervous system involvement, [...]
  • FDA clears procalcitonin test to hone antibiotic use in LRTI, sepsis

    on February 27th, 2017
    The Food and Drug Administration has cleared the expanded use of a procalcitonin test to help determine antibiotic use in patients with lower respiratory tract infections (LRTI) and sepsis. The Vidas Brahms PCT Assay (bioMérieux) uses procalcitonin levels to determine whether a patient with a lower[...]
  • Thrombotic microangiopathy may signal IV drug abuse

    on February 23rd, 2017
    FROM BLOOD Extended-release oxymorphone hydrochloride (Opana ER) tablets contain an inert ingredient that can trigger acute microangiopathic hemolytic anemia and thrombocytopenia in those who abuse the drug via intravenous injection, Ryan Hunt, of the Food and Drug Administration, and his colleagues[...]
  • Sarcoidosis doubles hospitalized infection risk

    on February 23rd, 2017
    FROM ANNALS OF THE AMERICAN THORACIC SOCIETY Persons with sarcoidosis were found to have double the risk of hospitalization, compared with age-matched controls in a population-based cohort study that also linked glucocorticoid use with an increased risk of hospitalization in this group. Using data f[...]
  • Lanadelumab reduced hereditary angioedema attacks by 88%-100%

    on February 22nd, 2017
    FROM THE NEW ENGLAND JOURNAL OF MEDICINE Lanadelumab, a monoclonal antibody that inhibits kallikrein, reduced attacks of hereditary angioedema with C1 inhibitor deficiency by 88%-100% in a small, phase I trial. Hereditary angioedema with C1 inhibitor deficiency is a rare disorder characterized by un[...]
  • Bowel obstruction surgery complications predicted with risk tool

    on February 7th, 2017
    AT THE EAST ANNUAL SCIENTIFIC ASSEMBLY HOLLYWOOD, FLA. (FRONTLINE MEDICAL NEWS) – A three-parameter scoring system predicts which patients are likely to experience complications from surgery for a small bowel obstruction. The new tool – dubbed FAS (Functional status, American Society of Anesthes[...]
  • HFNC bests conventional O2 therapy

    on February 6th, 2017
    FROM CHEST In patients with acute respiratory failure, high-flow nasal cannula (HFNC) is more reliable than is conventional oxygen therapy at reducing rates of endotracheal intubation, although no significant difference was found when HFNC was compared with noninvasive positive pressure ventilation,[...]
Back to top